Segment Information (Tables)

3 Months Ended

Sep. 30, 2023

Segment Reporting, Revenue Reconciling Item [Line Items]

Revenue from External Customers by Geographic Areas [Table Text Block]

The following table presents revenue by geographic area:

	Three Months Ended September 30,
(in millions)	2023		2022
United States	$	53,557	$	48,477
International	1,209		1,129
Total segment revenue	54,766		49,606
Corporate (1)	(3)		(3)
Total revenue	$	54,763	$	49,603

(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Revenue

The following table presents revenue for each reportable segment, disaggregated revenue within our two reportable segments and Corporate:

	Three Months Ended September 30,
(in millions)	2023		2022
Pharmaceutical and Specialty Pharmaceutical Distribution and Services (1)	$	50,682	$	45,547
Nuclear and Precision Health Solutions	324		281
Pharmaceutical segment revenue	51,006		45,828
Medical Products and Distribution (2)	3,076		3,140
Cardinal Health at-Home Solutions	684		638
Medical segment revenue	3,760		3,778
Total segment revenue	54,766		49,606
Corporate (3)	(3)		(3)
Total revenue	$	54,763	$	49,603

(1)Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.

(2)Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.

(3)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

Segment Profit by Reportable Segment

The following table presents segment profit by reportable segment and Corporate:

	Three Months Ended September 30,
(in millions)	2023		2022
Pharmaceutical	$	507	$	431
Medical	71		(8)
Total segment profit	578		423
Corporate	(592)		(286)
Total operating earnings/(loss)	$	(14)	$	137

Assets by Reportable Segment

The following table presents total assets for each reportable segment and Corporate at:

(in millions)	September 30, 2023		June 30, 2023
Pharmaceutical	$	28,968	$	28,077
Medical	9,425		10,130
Corporate	5,317		5,210
Total assets	$	43,710	$	43,417